top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato actin
active targeting
acute toxicity
adsorption
albumin
albumin nanoparticle
albumin nanoparticles
anacardic acid
angiogenesis
anti-cancer
anti-metastatic enzyme cancer therapy
anti-topoisomerase activity
anti-tumor immunity
antibody drug conjugate (ADC)
anticancer and antibacterial activity
antitumor strategy
apoptosis
ascorbic acid
BALB-neuT mice
biodistribution
biomimetic
biomimetic core-shell nanoparticles
biomimicry
bleeding
blood brain barrier
brain tumours
breast cancer
cabazitaxel
cancer
cancer diagnosis
cancer nanomedicine
cancer therapy
cathepsin D
cathepsin L
cats
cell signaling
cellular interaction
cellular microenvironment
chemico-physical functionalization
chemotherapeutics
chirality separation
clinical status
clinical translation
collagen
colloidal stability
colorectal carcinoma
combinatorial therapy
copper
CPMV
CSCs
cyclodextrins
cytotoxicity
diagnostics
differentiated neuroblastoma
dioleoylphosphatidylethanolamine
DNA origami
docetaxel
dogs
DOX
doxorubicin
drug combination
drug delivery
drug delivery system
drug-gene delivery
drug-in-cyclodextrin-in-liposome
dual-targeting
epithelial-to-mesenchymal transition
EPR effect
erlotinib
everolimus
exosomes
extracellular vesicles
FA-DABA-SMA
flow
folate
folate receptor
folic receptor alpha
glioblastoma
glioma
gold nanoparticles
gold nanorods
graphene oxide
hepatocellular carcinoma
hyaluronic acid
hyaluronidase
hybrid nanoparticles
hyperthermia
hyperthermia therapy
hypoxia
imaging
immune modulation
immunosuppression
immunotherapy
Immunotherapy
in situ vaccine
in vitro
in vitro anti-cancer activity
integrin
intra-arterial chemotherapy
intracellular disruption
intracranial glioma
iron affinity
lanthanide metal
ligand
lipid nanoparticles
liposome
liposomes
loading
lung cancer
lymphadenectomy
magnetic actuation
magnetic drug targeting
magnetic hyperthermia
magnetic nanoparticles
magnetic nanowires
magnetic silica-coated iron oxide nanochains
magnetometer
mammary carcinoma
mangiferin
MDA-MB-231
melanoma
membrane-wrapped
mesenchymal stem cells (MSCs)
Mesoporous silica nanoparticle
mesoporous silica nanoparticles
metabolism
microbubble
microfluidic
mitoxantrone
mixed micelle
molecular imaging
monoclonal antibodies
multicellular tumor spheroids
nano-bio interactions
nano-engineered MSCs
nanobiotechnology
nanocarrier
nanomedicine
nanomedicines
nanomicelles
nanoparticle
nanoparticles
nanostructured lipid carrier
nanosystems
nanotechnology: bioengineering
nanotherapeutics
NASH
near IR hyperspectral imaging
NK cell-derived exosomes
oncogenes
oncogenic proteins
organoids
organotin
orthotopic lung tumor model
osteopontin
ovarian cancer
ovarian carcinomatosis
oxidation-sensitive release
paclitaxel
pancreatic cancer
parvifloron D
passive targeting
PD-L1
PEGylation
peptidomimetics
pH responsive
photodynamic therapy
photodynamic therapy article
photothermal therapy
photothermal treatment
plasmonic photothermal therapy
plasmonics
platelet membrane
PLGA
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
polydopamine nanoparticles
polymeric nanoconstruct
polymeric nanoparticles
prostate cancer
radiotherapy
real-time quantitative polymerase chain reaction (qPCR)
remote loading
RGD peptide
riboflavin
secondary structure
self-assembly
sentinel lymph node dissection
shear stress
single-walled carbon nanotubes
siRNA
size
SN38
spheroids
SPION
stimuli-responsive
superparamagnetic iron oxide nanoparticles
surgery
target treatment
targeted delivery
targeted delivery system
targeted drug delivery
targeted therapy
TAT peptide
temoporfin
theranostic nanomaterials
theranostics
therapeutics
titanate nanotubes
translational medicine
triple negative breast cancer
tumor microenvironment
tumor spheroid disruption
tumor targeting
tumor vectorization
tumour microenvironment
tumour targeting
ultrasound
vectorization
VEGF
verteporfin
viral nanoparticles
vitamin B2
VX2 tumor
Vδ2 T cells
yet reasonably common within the subject discipline
zoledronic acid
β-cyclodextrin nanosponges
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato A4GALT
alpha-galactosidase A
animal models
astrogliosis
autophagy
axon guidance
biomarkers
bone involvement
cathepsin D
chloroquine
clathrin
Dkk1
dried blood spot
endocytic pathways
endocytosis
enzyme replacement therapy
exosomes
experimental therapies
Fabry disease
GAA biomarker
Gaucher disease
Gaucher Disease
gene therapy
GLA gene
globotriaosyl-sphingosine (lysoGb3)
globotriaosylceramide (Gb3)
globotriaosylsphingosine
glycogen
hematopoietic stem cell transplantations
Hurler syndrome
IGF2R/M6P
iPSC
Krabbe disease
lyso-Gb3
lysosomal diseases
lysosomal storage disorder
lysosomal storage disorders
lysosomal targeting
lysosomal α-glucosidase
lysosome
lysosomes
MIP-1β
mucolipidosis II
mucopolysaccharidosis IIIB
mucopolysaccharidosis type I
muscle
NAGLU
neurodegenerative disease
neuronal circuit
neuronopathy
newborn screening
Osteoimmunology
Osteopontin
Parkinson disease
pharmacological chaperone therapy
pharmacological chaperones
Pompe disease
precision medicine
psychosine
quantitative proteomics
RANK/RANKL
rhGAA
satellite cells
second tier test
sortilin
substrate reduction therapy
tandem mass spectrometry
TGF-beta
Twitcher mouse
variant interpretation
viral vectors
visual cortex
visual system
Wnt/β-catenin
Wnt3a
α-galactosidase A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Processing Technology of Dairy Products
Novel Processing Technology of Dairy Products
Autore Moschopoulou Ekaterini
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (118 p.)
Soggetto topico Industrial chemistry and chemical engineering
Technology: general issues
Soggetto non controllato ACE inhibitory activity
alkaline phosphatase
alpha-lactalbumin (α-Lac)
antioxidant capacity
beta-lactoglobulin (β-Lg)
biofunctionality
bovine milk
buttermilk
carbon footprint
casein fractions
cathepsin D
fermented dairy beverage
food hydrocolloids
gel properties
heat stability
high hydrostatic pressure
high pressure processing
high pressure processing (HPP)
high-pressure processing
image analysis
life-cycle assessment
membrane separation
methods for crystal structure evaluation
microbial inactivation
microfiltration
milk phospholipids
milk renneting properties
n/a
ovine milk
pasteurization
probiotics
ready-to-feed (RTF) infant formula
recrystallization
rheology
sensory quality
sheep milk
supercritical fluid extraction
total phenolic content
traditional yoghurt starter
viability model
whey protein hydrolysates
yoghurt
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580211503321
Moschopoulou Ekaterini  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy
Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy
Autore Kwok Hang Fai
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (93 p.)
Soggetto topico Research & information: general
Soggetto non controllato ADAMTS3
angiogenesis
apoptosis
Bowman-Birk inhibitor
cancer
cathepsin D
CCBE1
cysteine protease inhibitor
diversification
extracellular matrix
Gentamicin
immune response
KLK3
lymphangiogenesis
lymphedema
matrix metalloproteases
matrix metalloproteinase
metastasis
MMP
MMP14
MMP2
MMP7
MMP9
nuclei
pancreatic cancer
parasite
PDAC
phylogenetic analysis
plasmin
PlGF
prostate-specific antigen (PSA)
proteases
protein structure
proteolytic activation
ranacyclin
signal peptide
stefin
structure-activity relationship
synergistic effect
thrombin
trypsin inhibitor
vascular biology
vascular endothelial growth factors (VEGFs)
VEGF-A
VEGF-B
VEGF-C
VEGF-D
wound healing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557353103321
Kwok Hang Fai  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui